SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting highly positive Phase 2 S-OLARIS trial results for sonelokimab in axial spondyloarthritis, showcasing strong efficacy and potential disease-modifying effects. This, combined with a robust financial position and an eagerly awaited Investor Day, is fueling community discussion around significant undervaluation, a potential short squeeze, and best-in-class potential for its nanobody platform.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ trends as the market grapples with the fallout from the Supreme Court's tariff ruling and the subsequent 15% global tariffs, fueling community debate on economic uncertainty and the tech index's consistent resilience ahead of Nvidia's pivotal earnings.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending after receiving FDA approval for Bysanti, a new treatment for bipolar I disorder and schizophrenia, which was granted New Chemical Entity (NCE) status with patent protection extending to 2044. The community is actively discussing this as a major re-rating catalyst, anticipating significant institutional buying, and speculating on the drug's blockbuster potential alongside future pipeline developments.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amid renewed uncertainty surrounding global trade policy, driven by recent tariff decisions that have sparked market volatility. The community is sharply divided, with bears anticipating a major downturn following weekend declines, while bulls expect a typical 'V-shape' recovery, particularly ahead of key tech earnings this week.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

The recent acquisition of Astria Therapeutics, integrating the late-stage HAE drug navenibart, is driving BioCryst's conversation, especially with new data presentations for navenibart and Orladeyo expected at a medical conference and upcoming earnings. The community is actively discussing the potential of these pipeline advancements against persistent concerns about the stock's valuation and significant short interest.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending due to a dual financing announcement, including a non-dilutive royalty deal for its prostate cancer candidate and a concurrent public offering, which has sparked intense community debate over dilution and management's long-term commercialization strategy. Bulls view the capital raise as crucial validation and runway for its promising oncology pipeline, while bears express strong concerns about shareholder value and the impact on a potential "go it alone" approach.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF is trending with active debate around the Supreme Court's impending tariff ruling, as investors weigh the potential for a small-cap breakout if trade barriers ease against risks of new tariffs or wider market volatility. This uncertainty is fueling diverse technical outlooks and notable options hedging, highlighting its role as a key sentiment indicator.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Ryan Cohen's recent cryptic social media posts are driving intense speculation among investors about an imminent, monumental acquisition or strategic move, leveraging GameStop's substantial cash reserves. This dynamic fuels a fierce debate between ardent holders anticipating a massive short squeeze and skeptics citing ongoing price suppression and the absence of concrete company details.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is trending due to the expanding deployment of its driverless robotaxi services with Uber across the Middle East and the successful market entry of its WePilot ADAS system with major automotive OEMs, generating significant revenue growth and improved margins in its latest earnings report. The community actively discusses the stock's perceived undervaluation compared to its global operational achievements and increasing institutional backing, offset by a desire for more explicit near-term financial guidance from management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Promising Automotive Stocks To Watch Today - February 21st

O'Reilly Automotive, AutoZone, Monolithic Power Systems, Illinois Tool Works, Keysight Technologies, Rivian Automotive, and Genuine Parts are the seven Automotive stocks to watch today, according to...

Electric Vehicle Stocks To Watch Now - February 20th

Tesla, Rivian Automotive, BorgWarner, NIO, and QuantumScape are the five Electric Vehicle stocks to watch today, according to MarketBeat's stock screener tool. Electric vehicle stocks are shares of...

Automotive Stocks To Follow Today - February 20th

O'Reilly Automotive, AutoZone, Rivian Automotive, Monolithic Power Systems, and Keysight Technologies are the five Automotive stocks to watch today, according to MarketBeat's stock screener tool...

Vanguard Group Inc. Boosts Position in Rivian Automotive, Inc. $RIVN

Vanguard Group Inc. grew its holdings in shares of Rivian Automotive, Inc. (NASDAQ:RIVN - Free Report) by 3.3% in the 3rd quarter, according to the company in its most recent disclosure with the...

Why Rivian Stock Sank This Week

Key PointsRivian expects a sharp rise in EV deliveries this year...

Stevens Capital Management LP Takes $1.28 Million Position in Rivian Automotive, Inc. $RIVN

Stevens Capital Management LP purchased a new stake in Rivian Automotive, Inc. (NASDAQ:RIVN - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities...

Rivian Automotive (NASDAQ:RIVN) Shares Down 2.1% - Here's What Happened

Rivian Automotive (NASDAQ:RIVN) Shares Down 2.1% - Time to Sell...

Rivian Shares Surged on Delivery Forecast. Is It Too Late to Buy the Stock?

Key PointsRivian shares shot higher on strong delivery guidance...

Elon Musk's Net Worth Is So Large He Could Buy Ford, GM, Rivian And Toyota And Still Have $141 Billion Left

Elon Musk's net worth continues to rise in 2026 thanks to the merger of SpaceX and xAI. Here's how Musk's net worth compares to Tesla rival companies.read more...

Here is What to Know Beyond Why Rivian Automotive, Inc. (RIVN) is a Trending Stock

Rivian Automotive (RIVN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive (RIVN) stock price, news, forum, discussion, financials, community insights, and trading ideas, Join 10 million+ investors and traders tracking markets in real-time on Stocktwits

RIVN: Rivian Stock Price Today, News, Analysis, Trading Ideas

Tech stocks

Energy

Cash / Bonds

Crypto

What&#39;s your biggest portfolio allocation right now?

Stocktwits

What's your biggest portfolio allocation right now?

Stocktwits Polls

Rivian Automotive Inc

The upcoming R2 vehicle launch is driving intense discussion, with traders weighing its potential to significantly boost sales (targeting 67,000 total vehicles this year) against production and market reception challenges.

Controversial stock sales by the CEO and CFO post-earnings have fueled debate, with skeptics citing it as a bearish signal while supporters defend them as routine tax withholdings.

Technical analysts are closely monitoring price action for signs of a double or triple bottom formation and strong support around the 200 DMA, eyeing a potential reversal after recent declines.

RIVN
Rivian Automotive Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RIVN News

RIVNRivian Automotive Inc